Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07072143 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An International Study on Pediatric Patients With Rare Tumors.

Study acronym: PARTNER
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
1,739 trials monitored
See 106 trials at risk
1,092 trials monitored
See 60 trials at risk
and 2 more diseases
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
Trial Details
NCT Number NCT07072143
Lead Sponsor Azienda Ospedaliera di Padova
Collaborators: St. Anna Children's Hospital, Vienna, Children's Hospital Zagreb, Centre Hospitalier Universitaire de La Réunion, FRANCE, Klinikum Dortmund, University Children's Hospital Tuebingen, Hellenic Oncology Research Group, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Kaplan Medical Center, Rehovot, Israel, Vilnius University Hospital Santaros Klinikos, University of Skopje, Gdansk Medical University (Poland), Centro Hospitalar do Porto, Bucharest Emergency Hospital, Institute for Oncology and Radiology Serbia, Belgrade, University Hospital Bratislava, University Medical Centre Ljubljana, University of Bilbao, Göteborg University, University Hospital, Paris
Conditions
(from sponsor)
Paraganglioma/ Phaeochromocytoma, Melanoma and Other Malignant Neoplasms of Skin, Gastrointestinal Stromal Tumor (GIST), Adrenocortical Tumor, Pancreatic Tumors, Esthesioneuroblastoma, Olfactory, Mesothelioma, Nasopharyngeal Carcinoma (NPC) +6 more
Related terms Adrenal Cortex Neoplasms, Esthesioneuroblastoma, Olfactory, Gastrointestinal Stromal Tumors, Melanoma, Mesothelioma, Nasopharyngeal Carcinoma, Pancreatic Neoplasms, Pleuropulmonary blastoma, Thymus Neoplasms, Thyroid Neoplasms
Enrollment 6,250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov